MyFinsight
Home
Blog
About
Proceeds from clyra
medical debt...
$1,000K
(-20.70%↓ Y/Y)
Proceeds from sale of
common stock, net of...
$391K
Proceeds from beti unit
offering-Biolargo Energy...
$25K
Proceeds from clyra
medical stock option...
$5K
Net cash provided by
financing activities
$1,279K
(-65.42%↓ Y/Y)
Net effect of
foreign currency...
$3K
(115.00%↑ Y/Y)
Canceled cashflow
$158K
Net change in cash
-$1,934K
(-2411.69%↓ Y/Y)
Canceled cashflow
$1,282K
Stock option
compensation expense
$722K
(-34.78%↓ Y/Y)
Common stock issued for
services
$277K
(-16.82%↓ Y/Y)
Accounts payable and
accrued...
$174K
(-64.05%↓ Y/Y)
Amortization of debt discount
$70K
(4.48%↑ Y/Y)
Amortization of right-of-use
operating lease assets
$52K
(-5.45%↓ Y/Y)
Accounts payable and
accrued...
$33K
(-77.08%↓ Y/Y)
Depreciation expense
$33K
(-57.69%↓ Y/Y)
Amortization of right-of-use
finance lease asset
$28K
(-15.15%↓ Y/Y)
Prepaid expenses and
other assets
-$14K
(57.58%↑ Y/Y)
Credit loss expense
$13K
Repayment of clyra medical
line of credit
$134K
Repayment of debt
obligations
-$24K
(-366.67%↓ Y/Y)
Net cash used in
operating activities
-$3,056K
(22.59%↑ Y/Y)
Canceled cashflow
$1,416K
Net cash (used in)
provided by investing...
-$160K
(-183.33%↓ Y/Y)
Net income (loss),
including portion...
-$4,000K
(-5.18%↓ Y/Y)
Contract liabilities
-$273K
Deposits
-$105K
(-54.41%↓ Y/Y)
Operating lease
liabilities
-$51K
(-2.00%↓ Y/Y)
Finance lease liability
$25K
(-41.86%↓ Y/Y)
Inventories
$11K
(-90.35%↓ Y/Y)
Accounts receivable
$7K
(-99.70%↓ Y/Y)
Equipment purchases
$160K
Back
Back
Cash Flow
BIOLARGO, INC. (BLGO)
BIOLARGO, INC. (BLGO)
source: myfinsight.com